Triptolide Reduces Cholesterol Synthesis and Alleviates Neuroinflammation by Inhibiting CD33 in Alzheimer's Disease Development and Progression.

Overview

1. College of Life and Health Sciences, Northeastern University, Shenyang 110819, China
2. College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, which has recently been found to be closely associated with neuroinflammation. As an anti-inflammatory drug, triptolide (TP), a natural diterpenoid from Tripterygium wilfordii, was selected in the current study for treating PS19 (tauP301S transgenic) mice, tauopathy AD mice. In addition, we have previously found that TP had the ability to reduce the level of cholesterol. However, the roles and mechanisms of TP in the above processes are not clear. To this end, we found that elevated cholesterol in serum and brain tissues upregulated the expression of apolipoprotein E (APOE) and sialic acid-binding Ig-like lectin 3 (CD33), leading to the activation of SH2-containing protein tyrosine phosphatase 1 (SHP-1). The activation of SHP-1 inhibits the signaling pathways of Janus kinase 1 (JAK1) and signal transducer and activator of transcription 6 (STAT6), which results in inhibition of the M2 polarization of microglia, which exacerbates neuroinflammation and cognitive decline in high-cholesterol diet (HCD)-fed mice. Conversely, TP treatment significantly inhibited the hepatic sterol regulatory element-binding protein 2 (SREBP2)/3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) pathway, which reduced the cholesterol levels in the serum and brain. By depressing the levels of cholesterol, the axis of CD33 and SHP-1 was suppressed, which resulted in restoration of the activity of JAK1 and STAT6 pathways, leading to the transition of microglia from the M1 to the M2 phenotype. Of note, these observations demonstrate that TP alleviates the cognitive impairment of PS19 mice via depressing neuroinflammation. Altogether, our results revealed the mechanisms of TP in treating AD via CD33/SHP-1/JAK1/STAT6 pathways in a cholesterol-dependent manner.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Data Availability Statement

All experimental data supporting the findings of this study are declared available within the article by authors. The primary data, materials, detailed information and codes required to reanalyze the data in this work are available from the corresponding authors upon reasonable request.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 5 keywords, 3 funders, 46 references.

Cite

This paper

Yang, Y., Ma, Y., Wang, P., & Guan, P.-P. (2026). Triptolide Reduces Cholesterol Synthesis and Alleviates Neuroinflammation by Inhibiting CD33 in Alzheimer's Disease Development and Progression. Biology, 15(11), 818. https://doi.org/10.3390/biology15110818

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-026-74253-z

Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.

Journal: Nature communications

In common: Alzheimer's / dementia, mouse, cellular / molecular, 4 references

[2] doi:10.3389/fimmu.2026.1845312

Prenatal immune activation and adult Poly(I:C) re-challenge promote neuroimmune priming and AD-related behavioural, cellular and molecular alterations in wild-type mice.

Journal: Frontiers in immunology

In common: Alzheimer's / dementia, mouse, 3 references

[3] doi:10.1038/s41419-026-08862-3

O-GlcNAcylation reprograms microglial inflammatory states and attenuates Alzheimer's disease pathology.

Journal: Cell death & disease

In common: Alzheimer's / dementia, mouse, cellular / molecular, 2 references

[4] doi:10.1172/jci196112

Aging-dependent microglial heterogeneity worsens outcomes in models of traumatic brain injury.

Journal: The Journal of clinical investigation

In common: mouse, 2 references

[5] doi:10.3390/ijms27114756

Multi-Omics Integration and Causal Inference Identify HSD17B1 as a Potential Nobiletin Target Linking Neurosteroid Metabolism to Alzheimer's Disease.

Journal: International journal of molecular sciences

In common: Alzheimer's / dementia, cellular / molecular, 2 references

[6] doi:10.1016/j.apsb.2026.07.009

Neutrophil-mediated BDNF delivery for the treatment of moderate to severe Alzheimer's disease.

Journal: Acta pharmaceutica Sinica. B

In common: Alzheimer's / dementia, mouse, 2 references

[7] doi:10.1038/s43856-026-01707-2 [code]

Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease.

Journal: Communications medicine

In common: Alzheimer's / dementia, 2 references

[8] doi:10.3390/ijms27177542

Assessment of the Association of Periodontitis and Diabetes Mellitus with Alzheimer's Disease in a Mouse Model.

Journal: International journal of molecular sciences

In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference

[9] doi:10.1038/s44321-026-00482-w

Reducing CETP activity prevents memory decline in an Alzheimer's disease mouse model.

Journal: EMBO molecular medicine

In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference

[10] doi:10.1007/s00401-026-03018-1

Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.

Journal: Acta neuropathologica

In common: Alzheimer's / dementia, mouse, cellular / molecular, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.